When it comes to increasing vaccinations among older adults, a new report highlights the effectiveness of educating patients and encouraging clinicians to advocate for vaccination.

Data from the Phase II trial saw three of the seven patients dosed with CAN-2409 surviving for more than 35 months.

The increasing occurrence of genetic disorders is a major factor fueling the demand for oligonucleotide synthesis, as these molecules are essential for gene therapies and diagnostics aimed at ...

GSK PLC GSK shares advanced 2.13% to £14.84 Tuesday, on what proved to be an all-around positive trading session for the ...

Matha, in Quebec’s Lanaudière region, is dealing with an avian flu outbreak. It was first detected on Jan. 31 A primary ...

Levi & Korsinsky, LLP notifies investors in GSK plc ("GSK" or the "Company") of a class action securities lawsuit. CLASS ...

For the first time, the U.S. Department of Agriculture has confirmed the presence of H5N1 avian influenza in rats, raising ...

London, UK Tuesday, February 25, 2025, 15:00 Hrs [IST] GSK plc (GSK) announces the commencement of its share buyback programme (the “Progr ...

Hein Schumacher will step down as chief executive on 1 March, having only held the role since July 2023, before departing the ...

With Mayne Pharma subject to a $670 million takeover offer, investor attention turns to who might be acquired next.

GSK completes acquisition of Boston-based, clinical-stage biopharma company, IDRx, Inc.